Physician profile
David H Schmidt
NPI 1114017571
$430.19
in general payments reported to CMS, 2019-2025
15 companies · $54.77 in 2025
The $54.77 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $15.23 · 2023: $16.03 · 2024: $128 · 2025: $54.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $62.15 | 2019-2025 | Enhertu |
| Pfizer INC. | $55.25 | 2024 | |
| Daiichi Sankyo INC. | $44.90 | 2023-2025 | Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $40.79 | 2019-2025 | |
| Springworks Therapeutics, INC. | $36.84 | 2024 | Ogsiveo |
| Foundation Medicine, INC. | $27.32 | 2019 | |
| Celgene Corporation | $24.01 | 2019 | |
| Rigel Pharmaceuticals, INC. | $22.62 | 2019 | |
| Glaxosmithkline, LLC. | $21.36 | 2024 | Ojjaara |
| Medtronic USA, INC. | $18.96 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.59 | 2019 | |
| Agios Pharmaceuticals, INC. | $15.23 | 2020 | |
| Eisai INC. | $14.90 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $14.53 | 2019 | |
| Merck Sharp & Dohme LLC | $13.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.